Literature DB >> 1527057

Expression of calpain II gene in human hematopoietic system cells infected with human T-cell leukemia virus type I.

Y Adachi1, A Kitahara-Ozawa, K Sugamura, W J Lee, J Yodoi, M Maki, T Murachi, M Hatanaka.   

Abstract

We examined the distribution of calpains I and II in human hematopoietic system cell lines by Western and Northern blot analyses and enzyme activity assay. Expression of calpain I, a low Ca(2+)-requiring cysteine protease, was observed in all human T-cell lines tested. By contrast, expression of calpain II, a high Ca(2+)-requiring form, in human T-cells was closely correlated with human T-cell leukemia virus type I (HTLV-I) infection, which is known to result in the expression of adult T-cell leukemia-associated antigens, interleukin-2 (IL-2) receptor alpha, and Ca(2+)-dependent cell proliferation. Specific expression of calpain II in HTLV-I-infected cells occurred at the mRNA level. Furthermore, expression of calpain II in human natural killer-like cells was augmented by HTLV-I pX gene transfection. In HTLV-I-infected cells, the trans-acting transcriptional activation of the long terminal repeat and control elements for the IL-2 receptor alpha, c-fos, and granulocyte-macrophage colony-stimulating factor genes by the Tax from the pX gene is already known. Our results suggest that the similar trans-activation occurs to the calpain II gene in HTLV-I-infected hematopoietic system cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527057

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein.

Authors:  F T Stevenson; J Turck; R M Locksley; D H Lovett
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  CalpA, a Drosophila calpain homolog specifically expressed in a small set of nerve, midgut, and blood cells.

Authors:  U Theopold; M Pintér; S Daffre; Y Tryselius; P Friedrich; D R Nässel; D Hultmark
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

3.  Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases.

Authors:  T Mimori; K Suganuma; Y Tanami; T Nojima; M Matsumura; T Fujii; T Yoshizawa; K Suzuki; M Akizuki
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

4.  Roles of calpain-calpastatin system (CCS) in human T cell activation.

Authors:  Anna Mikosik; Aleksandra Jasiulewicz; Agnieszka Daca; Izabella Henc; Joanna E Frąckowiak; Katarzyna Ruckemann-Dziurdzińska; Jerzy Foerster; Aurelie Le Page; Ewa Bryl; Tamas Fulop; Jacek M Witkowski
Journal:  Oncotarget       Date:  2016-11-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.